Effects of the atrial antiarrhythmic drug AVE0118 on cardiac ion channels

Author： Gögelein Heinz   Brendel J.   Steinmeyer K.   Strübing C.   Picard N.   Rampe D.   Kopp K.   Busch A.   Bleich M.  

Publisher： Springer Publishing Company

ISSN： 0028-1298

Source： Naunyn-Schmiedeberg's Archives of Pharmacology, Vol.370, Iss.3, 2004-09, pp. : 183-192

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Analysis of the Surface Electrocardiogram for Monitoring and Predicting Antiarrhythmic Drug Effects in Atrial Fibrillation

By Husser Daniela   Stridh Martin   Sornmo Leif   Platonov Pyotr   Olsson S.   Bollmann Andreas  

Cardiovascular Drugs and Therapy, Vol. 18, Iss. 5, 2004-09 ,pp. : 377-386

Springer Publishing Company

Access to resources Recommend Favorite

Cardiac Sarcolemmal Ion Channels and Transporters as Possible Targets for Antiarrhythmic and Positive Inotropic Drugs: Strategies of the Past-Perspectives of the Future

By  

Current Pharmaceutical Design, Vol. 10, Iss. 20, 2004-08 ,pp. : 2411-2427

Bentham Science Publishers

Access to resources Recommend Favorite

Blockade of cardiac Na + channels by a charged class I antiarrhythmic agent, bisaramil: possible interaction of the drug with a pre-open closed state

By Sunami A.   Hiraoka M.  

European Journal of Pharmacology, Vol. 312, Iss. 2, 1996-09 ,pp. : 245-255

Elsevier

Access to resources Recommend Favorite

Novel Targets for Cardiac Antiarrhythmic Drug Development

By  

Current Pharmaceutical Design, Vol. 11, Iss. 15, 2005-06 ,pp. : 1959-1974

Bentham Science Publishers

Access to resources Recommend Favorite

Dofetilide: a class III anti-arrhythmic drug for the treatment of atrial fibrillation

By Torp-Pedersen C.   Brendorp B.   Køber L.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 11, 2000-11 ,pp. : 2695-2704

Informa Healthcare

Access to resources Recommend Favorite